MNTA  Momenta Pharmaceuticals Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

592.1M

Vuru Grade

51.00/100

Current Price

$11.56
+0.46 (+4.14%)

Growth Price

$33.63
Undervalued by 190.92%

Company Metrics

  • 13.83 P/E
  • 16.03 P/S
  • 2.11 P/B
  • -2.13 EPS
  • -466.87% Cash ROIC
  • 21.74 Cash Ratio
  • 0 / 0% Dividend
  • 895,882.00 Avg. Vol.
  • 51.22M Shares
  • 592.1M Market Cap.

Company Description

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development of generic versions of complex drug products, as well as for th...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.